Pandion Therapeutics

Pandion is an innovator in the development of localized immune-modulating therapies, focusing on creating bispecific antibodies for localized immune regulation. The company’s technology platform generates bispecific antibodies with targeting moieties that specifically bind to particular tissues involved in inflammatory diseases. Meanwhile, the effector portions of these antibodies can modulate immune activity, thereby restoring immune balance. The goal of this unique localized immune modulation approach is to provide long-term, tissue-specific efficacy at the disease site while avoiding systemic immunosuppression. This innovative treatment strategy has the potential to significantly enhance the therapeutic effects for autoimmune diseases and organ transplantation.